AQNEURSA Trademark
Trademark Overview
On Thursday, July 27, 2023, a trademark application was filed for AQNEURSA with the United States Patent and Trademark Office. The USPTO has given the AQNEURSA trademark a serial number of 98104776. The federal status of this trademark filing is NOTICE OF ALLOWANCE - ISSUED as of Tuesday, July 2, 2024. This trademark is owned by IntraBio Ltd. The AQNEURSA trademark is filed in the Pharmaceutical Products category with the following description:
pharmaceutical preparations for activating cellular function; pharmaceutical preparations for the prevention and treatment of diseases, disorders, or conditions of the nervous system; pharmaceutical preparations for treating sensory organ disorders; pharmaceutical preparations for treating nervous system injury or impairment; pharmaceutical preparations for use in the prevention and treatment of neurological and neurodegenerative diseases; drugs for medical purposes, namely, drugs for the prevention and treatment of neurological and neurodegenerative diseases; reagents for medical use; amino acid preparations for medical purposes
General Information
| Serial Number | 98104776 |
| Word Mark | AQNEURSA |
| Filing Date | Thursday, July 27, 2023 |
| Status | 688 - NOTICE OF ALLOWANCE - ISSUED |
| Status Date | Tuesday, July 2, 2024 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, May 7, 2024 |
Trademark Statements
| Goods and Services | pharmaceutical preparations for activating cellular function; pharmaceutical preparations for the prevention and treatment of diseases, disorders, or conditions of the nervous system; pharmaceutical preparations for treating sensory organ disorders; pharmaceutical preparations for treating nervous system injury or impairment; pharmaceutical preparations for use in the prevention and treatment of neurological and neurodegenerative diseases; drugs for medical purposes, namely, drugs for the prevention and treatment of neurological and neurodegenerative diseases; reagents for medical use; amino acid preparations for medical purposes |
Classification Information
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Sunday, August 27, 2023 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
Trademark Owner History
| Party Name | IntraBio Ltd |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 99 - Other |
| Address | London NW36BP
GB |
| Party Name | IntraBio Ltd |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 99 - Other |
| Address | London NW36BP
GB |
Trademark Events
| Event Date | Event Description |
| Monday, July 31, 2023 | NEW APPLICATION ENTERED |
| Sunday, August 27, 2023 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Thursday, March 28, 2024 | ASSIGNED TO EXAMINER |
| Friday, March 29, 2024 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, April 17, 2024 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, May 7, 2024 | PUBLISHED FOR OPPOSITION |
| Tuesday, May 7, 2024 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, July 2, 2024 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Thursday, September 26, 2024 | TEAS STATEMENT OF USE RECEIVED |
| Saturday, December 7, 2024 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
